Companies developing drug delivery technologies, such as plasters

Keylika is involved in the development of drug delivery technologies, specifically developing a small molecule iron drug delivered by a wearable skin patch, which is a type of plaster or transdermal delivery system.

Avro Life Science is involved in the development of drug delivery technologies and specifically offers skin patches for generic drug delivery, which aligns with the query's criteria for companies developing drug delivery technologies, such as plasters.

Kindeva Drug Delivery is involved in the development of drug delivery technologies, including transdermal delivery systems such as microneedle array patches, which are similar to plasters.

Cumberland Pharmaceuticals is involved in the development of drug delivery technologies and has a product, Sancuso, which is a transdermal patch for the treatment of nausea and vomiting in adults receiving chemotherapy. This matches the criteria of developing drug delivery technologies that include plasters or similar transdermal delivery systems.

Kinneir Dufort is involved in the development of innovative drug delivery systems, including patch injectors, which are similar to plasters in terms of transdermal delivery systems.

Avicanna is involved in the development of drug delivery technologies, including transdermal patches, which are similar to plasters. This is evidenced by their drug development pipeline that includes transdermal patches.

Sharp is involved in the development of drug delivery technologies and specifically offers commercial packaging services that include transdermal patches, which are similar to plasters.

Dyve Biosciences is involved in the development of drug delivery technologies through its DMAX transdermal platform, which delivers pH-modulating agents and other molecules. This platform includes transdermal delivery systems, which are similar to plasters.

CeQur SA is involved in the development of drug delivery technologies, specifically through their CeQur Simplicity patch, which is a transdermal delivery system for insulin.